about
Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesDysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin LymphomaA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.Current and emerging treatment options for Wiskott-Aldrich syndrome.A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsEpstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy.EBV and HIV-Related LymphomaHodgkin lymphoma in 2 children with chronic granulomatous disease.IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.Immune surveillance and lymphoid malignancy in immunocompromised host.B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiencyEpstein-Barr Virus (EBV) Prevalence and the Risk of Reactivation in Patients with Inflammatory Arthritis Using Anti-TNF Agents and in those who are Biologic Naive.Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomas.Hodgkin's and non-Hodgkin's lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature.Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.Establishing the carcinogenic risk of immunomodulatory drugs.Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment.Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?Predispositions to Lymphoma: A Practical Review for Genetic Counselors.Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopesA possible familial lymphoproliferative disorder in two male siblings of children with recurrent wheezing and lung infections since infancy.Iatrogenic lymphoproliferative disorder.Metachronous T-Lymphoblastic Lymphoma and Burkitt Lymphoma in a Child With Constitutional Mismatch Repair Deficiency Syndrome.Update on the management of the immunodeficiency in ataxia-telangiectasia.Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.Primary Epstein-Barr virus infection with neurological complications.
P2860
Q26829652-7CE2E006-5FAB-4BC8-92EA-6F87E0AB666FQ28071905-A83550EE-886B-42F7-A00E-7D041193A367Q30252766-31F8AEE3-A578-42BD-AE95-BFAC734E8189Q30850932-8A31294A-C3AA-462F-AE0D-515063487FD9Q31116522-9FF3C7F9-63FB-4109-A0DF-5148620114DEQ31145728-CB5B43C3-7357-4937-AB89-ED4FE64476F5Q33389727-B1152047-9731-4E2A-8477-41BC65CC37A8Q33397984-39CF49D6-C745-4CC5-8272-64CBD8E7BF50Q33424297-540A917F-1D69-4247-8A4D-B75E1976EF85Q33576286-5BD9F431-65A0-4E1B-81D8-37DF601E46A7Q33822062-CA43D8AF-1FA3-4F9C-A2FF-7CB209C9B076Q34180551-FCE9DA7B-E163-4CA3-8001-6494D8097FB1Q34549450-035FF20E-6BF2-4BD7-A67B-BE4666202CB0Q34571742-79B7F9A0-895A-4744-B386-5D816E38CE33Q34612668-AEAFC001-0616-482C-B263-6843CD299AA9Q34636731-236859ED-F58A-445C-BF9B-2B9AE2AA7B1BQ36831205-641BAEF6-7AC0-4E73-A057-E4FBA315A238Q37058863-85358A4A-08B2-49C2-91E3-5FF2BC75F0E0Q37271950-E88A3605-EA26-4719-851B-7BA557B0E77FQ37733809-3541B3C2-2267-4616-8D87-AEBDED4B7C1BQ37739415-19769E0E-EB84-4383-95A7-EDF0A84D3820Q37795414-F2DED1BE-3C8A-4365-BC14-C0F5B5DD52F8Q37959333-FC6B3744-22D5-4439-9F10-E29E8C489098Q38096060-768D4C65-C458-4AC5-9723-2F2592B2B5DDQ38186778-B5258059-A5D5-485D-AA69-E603CD1A5E91Q38855962-6D8F0D0A-2C2D-44B3-B59C-580427E6259DQ39301790-4CF602E4-F3AB-4562-A9C6-8E5437CADDECQ39367196-C3C6B869-CB44-4B62-970C-4CA646928211Q40117791-93FAB946-09E4-4923-BAE9-F1E2B4592F22Q40635545-2089D1D5-7DA8-4B30-B75C-3D0D50DCCEBFQ40856019-48531518-2DA1-4797-AC16-99455E33558DQ41457465-8DF51233-CD6C-4389-8EEC-AB468BC09A27Q42027228-5B4A5B6A-B9A2-4819-B913-D34090BB97F0Q42212205-E3BB0D5C-DC47-40DD-A7BA-5B0F74A3C489Q42224754-E30D69C5-5814-4B9D-9990-4595F913C36DQ42580084-6E5186A4-44C5-4707-8260-FDD8DC1C263AQ43061574-4F8414E9-6266-4DF2-9875-9BABD2DC5263Q44483454-B87C98AC-83A7-4872-8C8C-3126D475DA17Q45351817-8A986B7A-83FD-4FD4-8859-289425456E2FQ45371320-D6F97600-C5C3-437D-80E3-BA1A38B49DFF
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immunodeficiency-associated lymphomas.
@ast
Immunodeficiency-associated lymphomas.
@en
Immunodeficiency-associated lymphomas.
@nl
type
label
Immunodeficiency-associated lymphomas.
@ast
Immunodeficiency-associated lymphomas.
@en
Immunodeficiency-associated lymphomas.
@nl
prefLabel
Immunodeficiency-associated lymphomas.
@ast
Immunodeficiency-associated lymphomas.
@en
Immunodeficiency-associated lymphomas.
@nl
P2093
P1433
P1476
Immunodeficiency-associated lymphomas.
@en
P2093
Jamie Nourse
Maher K Gandhi
P304
P356
10.1016/J.BLRE.2008.03.009
P577
2008-05-05T00:00:00Z